Rare Diseases

Invitae Corporation (NYSE:NVTA) Sellers Increased By 11.19% Their Shorts

 Invitae Corporation (NYSE:NVTA) Sellers Increased By 11.19% Their Shorts

The stock of Invitae Corporation (NYSE:NVTA) registered an increase of 11.19% in short interest. NVTA’s total short interest was 3.44M shares in January as published by FINRA. Its up 11.19% from 3.09 million shares, reported previously. With 341,500 shares average volume, it will take short sellers 10 days to cover their NVTA’s short positions. The short interest to Invitae Corporation’s float is 14.42%.

The stock increased 2.81% or $0.26 during the last trading session, reaching $9.34. About 201,678 shares traded. Invitae Corporation (NYSE:NVTA) has risen 7.90% since January 2, 2017 and is uptrending. It has underperformed by 8.80% the S&P500.

Invitae Corporation, a genetic information company, focuses on bringing comprehensive genetic information into mainstream medical practice to enhance the quality of healthcare in the United States, Canada, Israel, and internationally. The company has market cap of $494.24 million. The firm processes DNA-containing samples, analyzes information about patient-specific genetic variation, and generates…